These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8539773)

  • 1. [Basis for the need for mass revaccination against measles and results of conducting it].
    Rykushin IuP; Deshevoĭ SE
    Tr Inst Im Pastera; 1992; 67():96-102. PubMed ID: 8539773
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles revaccination.
    Med Lett Drugs Ther; 1989 Jul; 31(797):69-70. PubMed ID: 2747586
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive measles vaccine].
    Gerike E; Rasch G
    Z Arztl Fortbild (Jena); 1990; 84(8):369-71. PubMed ID: 2378118
    [No Abstract]   [Full Text] [Related]  

  • 5. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revaccination against measles].
    Gerike E; Kirchner W; Pöhle W; Tischer A
    Z Gesamte Hyg; 1983 Feb; 29(2):62-5. PubMed ID: 6858258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 8. More on measles.
    Miller MA; Olivé JM; Strebel P
    Public Health Rep; 1999; 114(1):4-5. PubMed ID: 9925159
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measles morbidity in the RSFSR in a period of mass immunization].
    Ivanova LM; Gimpelevich SD
    Tr Inst Im Pastera; 1979; 53():7-12. PubMed ID: 162465
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of protection afforded by single measles vaccination and late revaccination schedules.
    Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E
    East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological assessment of the results of repeated inoculations against measles].
    Rykushin IuP; Deshevoĭ SE; Emel'ianova VI; Malykhina RM; Chudina LV
    Tr Inst Im Pastera; 1985; 62():40-6. PubMed ID: 2954274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiological bases for eliminating infectious diseases in extensive territories].
    Rykushin IuP
    Tr Inst Im Pastera; 1983; 61():4-20. PubMed ID: 6678510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results and prospects in the control of measles].
    Smorodintsev AA; Rykushin IuP
    Tr Inst Im Pastera; 1985; 62():21-5. PubMed ID: 3843362
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological characteristics of measles in mass vaccine prophylaxis and the prospects for its eradication].
    Smorodintsev AA; Rykushin IuP; Smorodintsev AlA
    Tr Inst Im Pastera; 1982; 57():10-6. PubMed ID: 6221441
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles immunization.
    Shulman ST
    J Fla Med Assoc; 1979 Nov; 66(11):1149-50. PubMed ID: 501326
    [No Abstract]   [Full Text] [Related]  

  • 18. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles infection following immunization: a report on forty-nine cases in Lagos, NIgeria.
    Williams GA
    Afr J Med Sci; 1971 Apr; 2(2):159-63. PubMed ID: 5111615
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles epidemics 1949-91: the impact of mass immunisation in New Zealand.
    Cullen RM; Walker WJ
    N Z Med J; 1996 Oct; 109(1032):400-2. PubMed ID: 8937390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.